Verzenio 150 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,046
Award facts
- Contract value 100% obligated
- $73,046.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $73,046.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4,570 tablets of Verzenio 150 mg (a breast cancer treatment medication) on January 28, 2026, with completion expected by January 29, 2026. This non-competitive delivery order represents a single-transaction fulfillment under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The contract award reflects the company's established capability to supply brand-name and specialty medications across multiple therapeutic domains through competitive federal procurement processes.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s broader $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (running through December 2031), which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally. The indefinite delivery contract encompasses a comprehensive range of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities required by military treatment facilities and veteran healthcare programs. No set-aside designation was applied to this award, indicating the contract was competitively awarded under full and open procurement procedures, consistent with AmerisourceBergen's federal contracting history.
Quick answers
Who was awarded contract SPE2DR26FQV4L?
SPE2DR26FQV4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV4L worth?
The government has obligated $73,046 on SPE2DR26FQV4L.
Is contract SPE2DR26FQV4L an order under another contract?
Yes. SPE2DR26FQV4L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV4L competed?
The extent of competition for SPE2DR26FQV4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award